International Journal of Biological Sciences, 2023 · DOI: 10.7150/ijbs.80672 · Published: May 8, 2023
Spinal cord injury (SCI) is a devastating neurological disorder that often results in loss of motor and sensory function. Diabetes facilitates the blood-spinal cord barrier (BSCB) destruction and aggravates SCI recovery. This study focused on transient receptor potential melastatin 2 (TRPM2) channel and investigated its regulatory role on integrity and function of BSCB in diabetes combined with SCI rat. The results confirmed that diabetes is obviously not conductive to SCI recovery through accelerates BSCB destruction. The mechanistic study demonstrated that under diabetic condition, TRPM2 mediates Ca2+ influx to activate calcium/calmodulin-dependent protein kinase (CaMKII)/eNOS in spinal cord after SCI, which in turn produces ROS production. Consequently, over-activation of TRPM2 ion channel results in excessive apoptosis and weaker angiogenesis during SCI recovery.
TRPM2 channel may be a key target for the treatment of diabetes combined with SCI.
TRPM2 inhibitors can be explored as potential drugs to ameliorate BSCB destruction and improve SCI recovery in diabetic patients.
Monitoring TRPM2 expression levels in diabetic SCI patients could help assess BSCB integrity and predict recovery outcomes.